Key result
Diabetic autonomic neuropathy is a major contributing factor in the morbidity of silent myocardial ischemia and infarction among patients suffering from diabetes mellitus.
Why the study?
Many MIs are asymptomatic or atypical, particularly in diabetic patients who report angina less frequently, prompting investigation into the relationship between DM, diabetic neuropathy, and silent myocardial ischemia and infarction.
Does diabetic autonomic neuropathy increase the risk of silent myocardial ischemia and infarction in patients with diabetes mellitus?
Design
Literature review
Authors
Loading...
Supports monitoring for silent ischemia in DM with DAN; extends observational data but leaves open prospective validation.
Does diabetic autonomic neuropathy increase the risk of silent myocardial ischemia and infarction in patients with diabetes mellitus?
Diabetic autonomic neuropathy is a major risk factor for the development of silent myocardial ischemia and infarction in patients with diabetes.
Kamara et al. (2020) conducted a review in Diabetes Mellitus and Silent Myocardial Ischemia/Infarction. Diabetic autonomic neuropathy vs. Absence of diabetic autonomic neuropathy was evaluated on Silent myocardial ischemia and infarction. Diabetic autonomic neuropathy is a major contributing factor in the morbidity of silent myocardial ischemia and infarction among patients suffering from diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: